These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38201483)

  • 1. Implementing an On-Slide Molecular Classification of Gastric Cancer: A Tissue Microarray Study.
    Costache S; de Havilland R; Diaz McLynn S; Sajin M; Baltan A; Wedden S; D'Arrigo C
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201483
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementing an integrated molecular classification for gastric cancer from endoscopic biopsies using on-slide tests.
    Costache S; Baltan A; Diaz McLynn S; Pegoraro M; de Havilland R; Porter M; Lerga A; Thomas T; Chefani AE; Wedden S; Billingham K; D'Arrigo C
    Rom J Morphol Embryol; 2024; 65(2):257-265. PubMed ID: 39020540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer.
    Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J
    Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
    Koh J; Lee KW; Nam SK; Seo AN; Kim JW; Kim JW; Park DJ; Kim HH; Kim WH; Lee HS
    Oncologist; 2019 Dec; 24(12):e1321-e1330. PubMed ID: 31371521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
    Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
    [No Abstract]   [Full Text] [Related]  

  • 6. A consolidated working classification of gastric cancer for histopathologists (Review).
    Costache S; Sajin M; Wedden S; D'Arrigo C
    Biomed Rep; 2023 Sep; 19(3):58. PubMed ID: 37614984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
    Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
    Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.
    Hewitt LC; Inam IZ; Saito Y; Yoshikawa T; Quaas A; Hoelscher A; Bollschweiler E; Fazzi GE; Melotte V; Langley RE; Nankivell M; Cunningham D; Allum W; Hutchins GG; Grabsch HI
    Eur J Cancer; 2018 May; 94():104-114. PubMed ID: 29550565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
    Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
    Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
    Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
    Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
    World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
    Di Pinto F; Armentano R; Arborea G; Schena N; Donghia R; Valentini AM
    Oncology; 2020; 98(8):566-574. PubMed ID: 32316005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actionable gene-based classification toward precision medicine in gastric cancer.
    Ichikawa H; Nagahashi M; Shimada Y; Hanyu T; Ishikawa T; Kameyama H; Kobayashi T; Sakata J; Yabusaki H; Nakagawa S; Sato N; Hirata Y; Kitagawa Y; Tanahashi T; Yoshida K; Nakanishi R; Oki E; Vuzman D; Lyle S; Takabe K; Ling Y; Okuda S; Akazawa K; Wakai T
    Genome Med; 2017 Oct; 9(1):93. PubMed ID: 29089060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
    Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
    Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer.
    Dislich B; Blaser N; Berger MD; Gloor B; Langer R
    Histopathology; 2020 Apr; 76(5):740-747. PubMed ID: 31898331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical impact of testing for biomarkers in gastric cancer patients: a real-world cohort.
    van der Sluis K; van Sandick JW; van Dieren JM; Vollebergh MA; Grootscholten C; van den Berg JG; Snaebjornsson P; Hartemink KJ; Veenhof AAFA; Chalabi M; Kodach LL
    Histopathology; 2023 May; 82(6):826-836. PubMed ID: 36694277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.
    Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J
    PeerJ; 2021; 9():e11481. PubMed ID: 34046266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
    Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
    Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic Features and Prognostic Significance of Immunohistochemistry and In Situ Hybridization Based Molecular Classification in Gastric Carcinoma.
    Issin G; Sayar İ; Demir F; Bakkaloğlu İG; Gamsizkan M; Yildiz Z; Yilmaz I; Özmen SA; Çağatay DV; Zemheri IE; Demiriz M; Günal A
    J Environ Pathol Toxicol Oncol; 2023; 42(4):1-14. PubMed ID: 37522564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.